NADH

Most people never think about how their cells actually turn food into usable energy. NADH (nicotinamide adenine dinucleotide, reduced form) sits at the center of that process, and when its balance with its oxidized partner gets thrown off, the consequences ripple out into how your mitochondria perform, how your body handles sugar and fat, and how well your cells cope with metabolic stress.

This is a newer measurement without standardized clinical cutpoints, and it is not part of routine lab panels. That is exactly why getting a baseline now and tracking your trend over time gives you a head start. You will have your own data to compare against as the science matures, and you will see how lifestyle changes shift your number.

What NADH Actually Does Inside Your Cells

NADH is the reduced (electron-carrying) form of NAD+. Think of NAD+ and NADH as the same shuttle in two different states. NAD+ picks up electrons from food molecules as your cells break them down, becoming NADH, which then hands those electrons off to the energy-producing machinery inside your mitochondria (the energy compartments inside your cells). Your mitochondria use those electrons to make ATP, the fuel that powers nearly everything you do.

This shuttle runs in nearly every cell, but the demand is highest in tissues with intense energy needs. The heart has very high NAD levels because of its dense mitochondria and constant metabolic workload. NADH is also generated in your cytoplasm during the first stages of breaking down glucose, and the liver plays a central role in building NAD from scratch using the amino acid tryptophan and then exporting it to other tissues.

What matters most is not NADH alone but the ratio of NAD+ to NADH. That ratio is one of the body's most fundamental signals of cellular redox balance (the give-and-take of electrons that keeps cells working properly). When the ratio tilts toward too much NADH, cells experience what researchers call reductive stress, a state where electrons are piling up faster than the machinery can use them.

Mitochondrial Disease

The clearest evidence linking NADH to clinical outcomes comes from inherited mitochondrial disorders. In patients with the m.3243A>G mutation, the most common cause of MELAS (a rare condition that causes brain injury, lactic acidosis, and stroke-like episodes), an elevated NADH-to-NAD+ ratio tracks closely with how severe the disease is. A panel of circulating markers that reflect this NADH buildup, including lactate, alanine, GDF-15 (a stress protein), and several beta-hydroxy fatty acids, was more informative than lactate measured alone, with 20 analytes validated in an independent cohort.

A similar pattern shows up in Leigh syndrome, another rare mitochondrial condition. Studies of patient fibroblasts (connective tissue cells obtained from a small skin biopsy) found that elevated NADH levels correlated with disease severity, and researchers proposed that NADH-reductive stress could outperform standard lactate measurement as a marker of progression.

Diabetes and Insulin Resistance

High blood sugar and elevated free fatty acids drive NADH to accumulate in both the cytoplasm and the mitochondria. This buildup contributes to several diabetic complications, including nerve damage, heart muscle disease, and kidney injury. A high NADH-to-NAD+ ratio impairs sirtuin-3 (an enzyme that helps regulate fat burning), disrupts fatty acid breakdown, and worsens oxidative stress, all mechanisms that feed forward into insulin resistance.

A community-based cross-sectional study of 1,394 adults (the Jidong study) examined blood total NAD levels (not NADH specifically) in relation to metabolic disease. Compared with people in the lowest quarter of NAD levels, those in the highest quarter were about three times as likely to have metabolic disease overall (adjusted odds ratio 3.01, 95% CI 1.87 to 4.87), and roughly four times as likely to have three to six metabolic disease components (adjusted odds ratio 4.30, 95% CI 2.32 to 7.98). The association held after adjusting for age, sex, drinking, and smoking.

Reconciling the Counterintuitive Finding

That last result probably surprises you. Most longevity coverage treats more NAD as universally good. Why would higher NAD track with more metabolic disease? The answer is that this is not a simple good number / bad number marker. The Jidong study measured total NAD, not NADH specifically, and the broader NAD pool reflects the state of cellular metabolism. Different states of dysfunction can push the system in different directions. Higher total NAD in someone with metabolic syndrome may reflect a stressed metabolic state rather than a healthy one, while age-related decline in NAD in another person reflects a different problem entirely. The ratio of NAD+ to NADH, and the context of your other lab work, matters more than chasing a single number up or down.

Heart Failure and Cardiovascular Disease

In a small case-control comparison, healthy blood donors (aged 19 to 68) had a mean whole-blood NAD concentration of 23.4 micromolar (a unit measuring very small concentrations), compared with 20.7 micromolar in geriatric patients (aged 75 to 101) hospitalized for heart failure, a roughly 12% difference. Because the two groups also differ markedly in age, part of that gap likely reflects age-related decline rather than heart failure alone. A separate analysis of healthy controls found whole-blood NAD around 18 micromolar, with even lower levels (around 13 micromolar) in patients with cardiac disease. Altered NAD-to-NADH ratios are thought to contribute to heart failure, injury after restored blood flow, arrhythmia, and high blood pressure.

Aging

NAD levels generally decline with age across tissues including liver, skin, muscle, pancreas, and fat. In the brain, the pattern is different: NADH increases while NAD+ decreases in older adults. A study of plasma NAD across ages 18 to 83 found women showed higher NAD-to-NADH ratios than men in younger adulthood, a difference that narrowed with age. Plasma total NAD itself did not show a uniform age-related decline in that study, so tissue-level patterns and circulating patterns are not always synchronized.

Why One Reading Is Not Enough

A single NADH value tells you very little. NAD biosynthesis follows a circadian rhythm, meaning your level shifts throughout the day. Acute factors like recent exercise, fasting, and even illness can move the number. The most useful approach is to get a baseline, retest in 3 to 6 months if you are making lifestyle changes (sleep, exercise, alcohol intake), and then check at least annually after that to track your direction of travel.

Encouragingly, one study using a fingerstick blood assay demonstrated long-term stability of an individual's NAD baseline over 100 days, suggesting that under steady conditions each person has their own characteristic set point. That makes serial testing meaningful: you are not looking for population norms, you are watching your own trend.

When Results Can Be Misleading

• Sample handling fragility: NADH is one of the more delicate molecules in a blood tube. Levels can drop substantially within a single business day unless samples are processed with proper precautions. Cellular metabolism in the sample needs to be quenched quickly, and even minimal cell breakage can dramatically skew results because intracellular NADH is far more concentrated than the extracellular kind.
• Recent intense exercise: A bout of hard exercise temporarily raises muscle NADH, with one study showing values climbing from about 0.089 mmol/kg at rest to 0.213 mmol/kg at exhaustion. These shifts can persist for hours to a couple of days. Test on a normal day, not the morning after a workout you would describe as brutal.
• Time of day: NAD biosynthesis is governed by your internal clock, so the time you draw blood matters. Try to test at roughly the same time each round to make your serial readings comparable.
• Acute alcohol intake: Ethanol metabolism rapidly converts NAD+ to NADH in the liver, distorting the ratio. Avoid alcohol for at least 24 to 72 hours before testing.

What to Do With an Unexpected Result

Because this is a research-grade marker without validated clinical cutpoints, a single out-of-pattern result should prompt context-building rather than panic. Repeat the test under standardized conditions (same time of day, no alcohol, no recent intense exercise). Look at your result alongside markers that reflect related biology: lactate, fasting glucose and HbA1c, a full lipid panel, liver enzymes, and inflammation markers like hs-CRP.

Patterns matter more than any one number. A persistently elevated NADH alongside rising fasting glucose, climbing triglycerides, and worsening liver enzymes is a different story than an isolated finding in someone whose other metabolic markers look clean. If you have a personal or family history of mitochondrial disease, an elevated NADH-reductive stress signal is worth raising with a specialist who treats metabolic or mitochondrial disorders. For most people, the value of this test lies in tracking direction over years and using the trend to gauge whether your lifestyle interventions are moving the dial.